Taysha Gene Therapies to Release Third Quarter 2022 Financial Results and Host Conference Call and Webcast on November 8

November 2, 2022

https://www.globenewswire.com/news-release/2022/11/02/2546298/0/en/Taysha-Gene-Therapies-to-Release-Third-Quarter-2022-Financial-Results-and-Host-Conference-Call-and-Webcast-on-November-8.html

DALLAS, Nov. 02, 2022 (GLOBE NEWSWIRE) — Taysha Gene Therapies, Inc. (Nasdaq:TSHA), a patient-centric, pivotal-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system (CNS) in both rare and large patient populations, today announced that it will report its financial results for the third quarter ended September 30, 2022, and host a corporate update conference call and webcast on Tuesday, November 8, 2022, at 8:00 AM Eastern Time.

Read more at globenewswire.com

Related news for (TSHA)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.